AN2 Therapeutics Net Tangible Assets

AN2 Therapeutics (ANTX) currently reports a net tangible assets of $82M as of March 2026. That compares with $73M in the prior-year period — up 11.5% year over year. Use the charts on this page to explore AN2 Therapeutics's net tangible assets history and peer comparisons.

AN2 Therapeutics's net tangible assets increased from $73M to $82M — a 11.5% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

AN2 Therapeutics reported $82M in net tangible assets as of March 2026. That compares with $73M in the prior-year period — up 11.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $82M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for AN2 Therapeutics, and consider following ANTX for alerts when major investors trade the stock.